Everest Organics Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for Everest Organics Ltd indicates a neutral stance on the stock, suggesting that investors should neither aggressively buy nor sell at this time. This rating reflects a balanced view of the company’s prospects, considering both strengths and challenges. The rating was revised from 'Sell' to 'Hold' on 05 August 2025, following an improvement in the company’s overall Mojo Score from 44 to 50 points, signalling a modest enhancement in its investment appeal.

Here’s How Everest Organics Looks Today

As of 05 February 2026, Everest Organics Ltd operates as a microcap within the Pharmaceuticals & Biotechnology sector. The company’s current Mojo Grade is 'Hold', supported by a composite assessment of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall rating and offers insight into the stock’s investment potential.

Quality Assessment

The quality grade for Everest Organics is below average, reflecting some fundamental weaknesses. Over the past five years, the company has experienced a negative compound annual growth rate (CAGR) of -9.29% in operating profits, indicating challenges in sustaining long-term profitability. Additionally, Everest Organics has a high Debt to EBITDA ratio of 6.46 times, which suggests a relatively weak ability to service its debt obligations. The average Return on Equity (ROE) stands at 5.58%, signalling modest profitability relative to shareholders’ funds. These factors collectively temper the stock’s quality profile, cautioning investors about underlying operational risks.

Valuation Considerations

Currently, Everest Organics is considered expensive based on valuation metrics. The company’s Return on Capital Employed (ROCE) is 9.1%, and it trades at an Enterprise Value to Capital Employed ratio of 3.7 times. Despite this, the stock is priced at a discount relative to its peers’ historical valuations, which may offer some valuation comfort. The price-to-earnings-to-growth (PEG) ratio is notably low at 0.3, reflecting that the stock’s price growth is not fully aligned with its earnings growth potential. This valuation profile suggests that while the stock may appear costly on some measures, there could be latent value given its growth trajectory.

Financial Trend and Recent Performance

The financial trend for Everest Organics is very positive, highlighting recent operational improvements. The company reported an 8.62% growth in operating profit in the quarter ending September 2025 and has declared positive results for four consecutive quarters. Net sales for the latest six months reached ₹104.81 crores, growing by 37.01%, while profit after tax (PAT) for the same period surged by 148.04% to ₹2.57 crores. The operating profit to interest coverage ratio is robust at 4.17 times, indicating improved capacity to meet interest expenses. Over the past year, the stock has delivered a remarkable 50.44% return, outpacing many peers, while profits have risen by 225.6%. These figures underscore a strong recent turnaround and enhanced financial health.

Technical Outlook

Technically, Everest Organics is mildly bullish. The stock has shown mixed short-term price movements, with a 1-day change of -0.01%, a 1-week gain of 3.14%, and a 3-month increase of 7.35%. However, it has experienced a 1-month decline of 17.74% and a year-to-date drop of 17.95%. Despite these fluctuations, the six-month return of 29.49% and the one-year gain of 50.44% indicate underlying strength and investor interest. The technical grade supports the 'Hold' rating by signalling cautious optimism without strong momentum for immediate buying.

Ownership and Market Capitalisation

Everest Organics remains a microcap stock with majority ownership held by promoters. This concentrated ownership structure can provide stability but may also limit liquidity and broader market participation. Investors should consider this factor when evaluating the stock’s risk profile.

What the Hold Rating Means for Investors

For investors, the 'Hold' rating on Everest Organics suggests a wait-and-watch approach. The company’s improving financial trend and positive recent results provide reasons for cautious optimism. However, the below-average quality metrics and expensive valuation warrant prudence. Investors may consider maintaining existing positions while monitoring upcoming quarterly results and sector developments closely. The rating implies that the stock is not currently undervalued enough to warrant a buy, nor does it exhibit sufficient risk factors to justify selling.

Sector and Market Context

Operating within the Pharmaceuticals & Biotechnology sector, Everest Organics faces a competitive and rapidly evolving market environment. The sector often demands strong innovation and consistent profitability to attract premium valuations. Everest Organics’ recent financial improvements are encouraging, but the company’s long-term growth challenges and debt levels remain concerns. Investors should weigh these factors against broader sector trends and peer performance when making allocation decisions.

Summary

In summary, Everest Organics Ltd’s current 'Hold' rating by MarketsMOJO, last updated on 05 August 2025, reflects a balanced view of the company’s prospects as of 05 February 2026. While recent financial trends and stock returns are positive, underlying quality and valuation metrics suggest caution. The stock’s mild technical bullishness and promoter backing add further nuance to its investment profile. This rating advises investors to maintain positions with vigilance, awaiting clearer signals before committing additional capital.

Unlock special upgrade rates for a limited period. Start Saving Now →